| Dr Fitzgerald Alcindor, MD | |
|
2459 Merrick Rd, Bellmore, NY 11710-5703 | |
| (516) 826-2273 | |
| (516) 826-2272 |
| Full Name | Dr Fitzgerald Alcindor |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 33 Years |
| Location | 2459 Merrick Rd, Bellmore, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396832978 | NPI | - | NPPES |
| 01996881 | Medicaid | NY |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| City Medical Of Upper East Side Pllc | 0648465039 | 759 |
| Tempo Group, Inc. | 5799877262 | 5 |
News Archive
Patheon a global provider of drug development and manufacturing services to the international pharmaceutical industry today announced results for the fourth quarter and full year ended October 31, 2009.
Neuroblastoma, the most common malignant tumor of early childhood, is frequently associated with the presence of MYCN amplification, a genetic biomarker associated with poor prognosis. Researchers have determined that tumors containing MYCN amplification are sensitive to a new class of drugs, BET bromodomain inhibitors.
October is national SIDS (Sudden Infant Death Syndrome) Awareness Month and recognized by the State of New Jersey through a proclamation signed by Governor Chris Christie, calling attention to one of the leading causes of infant mortality.
On the sidelines of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) on Tuesday, "representatives of governments, civil society and the private sector joined United Nations agencies ... to emphasize the importance of good nutrition, which is vital not only for human health but also for national economic and social development," the U.N. News Centre reports.
› Verified 6 days ago
| Entity Name | City Medical Of Upper East Side Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801277629 PECOS PAC ID: 0648465039 Enrollment ID: O20101111000052 |
News Archive
Patheon a global provider of drug development and manufacturing services to the international pharmaceutical industry today announced results for the fourth quarter and full year ended October 31, 2009.
Neuroblastoma, the most common malignant tumor of early childhood, is frequently associated with the presence of MYCN amplification, a genetic biomarker associated with poor prognosis. Researchers have determined that tumors containing MYCN amplification are sensitive to a new class of drugs, BET bromodomain inhibitors.
October is national SIDS (Sudden Infant Death Syndrome) Awareness Month and recognized by the State of New Jersey through a proclamation signed by Governor Chris Christie, calling attention to one of the leading causes of infant mortality.
On the sidelines of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) on Tuesday, "representatives of governments, civil society and the private sector joined United Nations agencies ... to emphasize the importance of good nutrition, which is vital not only for human health but also for national economic and social development," the U.N. News Centre reports.
› Verified 6 days ago
| Entity Name | Tempo Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144206376 PECOS PAC ID: 5799877262 Enrollment ID: O20190813000379 |
News Archive
Patheon a global provider of drug development and manufacturing services to the international pharmaceutical industry today announced results for the fourth quarter and full year ended October 31, 2009.
Neuroblastoma, the most common malignant tumor of early childhood, is frequently associated with the presence of MYCN amplification, a genetic biomarker associated with poor prognosis. Researchers have determined that tumors containing MYCN amplification are sensitive to a new class of drugs, BET bromodomain inhibitors.
October is national SIDS (Sudden Infant Death Syndrome) Awareness Month and recognized by the State of New Jersey through a proclamation signed by Governor Chris Christie, calling attention to one of the leading causes of infant mortality.
On the sidelines of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) on Tuesday, "representatives of governments, civil society and the private sector joined United Nations agencies ... to emphasize the importance of good nutrition, which is vital not only for human health but also for national economic and social development," the U.N. News Centre reports.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Fitzgerald Alcindor, MD 1345 Rxr Plz, Uniondale, NY 11556-1301 Ph: (516) 453-0435 | Dr Fitzgerald Alcindor, MD 2459 Merrick Rd, Bellmore, NY 11710-5703 Ph: (516) 826-2273 |
News Archive
Patheon a global provider of drug development and manufacturing services to the international pharmaceutical industry today announced results for the fourth quarter and full year ended October 31, 2009.
Neuroblastoma, the most common malignant tumor of early childhood, is frequently associated with the presence of MYCN amplification, a genetic biomarker associated with poor prognosis. Researchers have determined that tumors containing MYCN amplification are sensitive to a new class of drugs, BET bromodomain inhibitors.
October is national SIDS (Sudden Infant Death Syndrome) Awareness Month and recognized by the State of New Jersey through a proclamation signed by Governor Chris Christie, calling attention to one of the leading causes of infant mortality.
On the sidelines of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) on Tuesday, "representatives of governments, civil society and the private sector joined United Nations agencies ... to emphasize the importance of good nutrition, which is vital not only for human health but also for national economic and social development," the U.N. News Centre reports.
› Verified 6 days ago